Stocks AMAT Financial statements
Financial statementsAPPLIED MATERIALS INC /DE financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data APPLIED MATERIALS INC /DE files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,825 | 14,698 | 16,705 | 14,608 | 17,202 | 23,063 | 25,785 | 26,517 | 27,176 | 28,368 |
| Cost of revenue | 6,314 | 8,086 | 9,188 | 8,222 | 9,510 | 12,149 | 13,792 | 14,133 | 14,279 | 14,560 |
| Gross profit | 4,511 | 6,612 | 7,517 | 6,386 | 7,692 | 10,914 | 11,993 | 12,384 | 12,897 | 13,808 |
| Research and development | 1,540 | 1,781 | 2,022 | 2,054 | 2,234 | 2,485 | 2,771 | 3,102 | 3,233 | 3,570 |
| Selling, general and administrative | 1,628 | 1,797 | 1,768 | |||||||
| Selling and marketing | 429 | 457 | 521 | 521 | 526 | 609 | 703 | 776 | 836 | 858 |
| General and administrative | 390 | 438 | 483 | 461 | 567 | 620 | 735 | 852 | 961 | 910 |
| Operating expenses | 2,359 | 2,676 | 3,026 | 3,036 | 3,327 | 4,025 | 4,205 | 4,730 | 5,030 | 5,519 |
| Operating income | 2,152 | 3,936 | 4,491 | 3,350 | 4,365 | 6,889 | 7,788 | 7,654 | 7,867 | 8,289 |
| Interest expense | 155 | 198 | 234 | 237 | 240 | 236 | 228 | 238 | 247 | 269 |
| Interest income | 262 | 486 | 406 | |||||||
| Other non-operating income | 16 | 78 | 139 | 156 | 41 | 118 | 39 | 300 | 532 | 1,251 |
| Pre-tax income | 2,013 | 3,816 | 4,396 | 3,269 | 4,166 | 6,771 | 7,599 | 7,716 | 8,152 | 9,271 |
| Income tax | 292 | 297 | 1,358 | 563 | 547 | 883 | 1,074 | 860 | 975 | 2,273 |
| Net income | 1,721 | 3,519 | 3,038 | 2,706 | 3,619 | 5,888 | 6,525 | 6,856 | 7,177 | 6,998 |
| EBITDA | 2,541 | 4,343 | 4,948 | 3,713 | 4,741 | 7,283 | 8,232 | 8,169 | 8,259 | 8,724 |
| EPS, basic | 1.56 | 3.28 | 3.00 | 2.89 | 3.95 | 6.47 | 7.49 | 8.16 | 8.68 | 8.71 |
| EPS, diluted | 1.54 | 3.25 | 2.96 | 2.86 | 3.92 | 6.40 | 7.44 | 8.11 | 8.61 | 8.66 |
| Shares, basic (weighted) | 1,107 | 1,073 | 1,013 | 937 | 916 | 910 | 871 | 840 | 827 | 804 |
| Shares, diluted (weighted) | 1,116 | 1,084 | 1,026 | 945 | 923 | 919 | 877 | 845 | 834 | 808 |
| Dividend per share | 0.10 | 0.10 | 0.70 | 0.83 | 0.87 | 0.94 | 1.02 | 1.22 | 1.52 | 1.78 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3,406 | 5,010 | 3,440 | 3,129 | 5,351 | 4,995 | 1,995 | 6,132 | 8,022 | 7,241 |
| Short-term investments | 343 | 2,266 | 590 | 489 | 387 | 464 | 586 | 737 | 1,449 | 1,332 |
| Receivables | 2,279 | 2,338 | 2,323 | 2,533 | 2,963 | 4,953 | 6,068 | 5,165 | 5,234 | 5,185 |
| Inventory | 2,050 | 2,707 | 3,721 | 3,474 | 3,904 | 4,309 | 5,932 | 5,725 | 5,421 | 5,915 |
| Other current assets | 275 | 374 | 530 | 581 | 764 | 1,386 | 1,344 | 1,388 | 1,094 | 1,208 |
| Total current assets | 8,353 | 12,918 | 10,604 | 10,206 | 13,369 | 16,107 | 15,925 | 19,147 | 21,220 | 20,881 |
| Property, plant and equipment | 937 | 1,066 | 1,407 | 1,529 | 1,604 | 1,934 | 2,307 | 2,723 | 3,339 | 4,610 |
| Lease right-of-use assets | 0 | 252 | 294 | 389 | 370 | 375 | 509 | |||
| Goodwill | 3,316 | 3,368 | 3,368 | 3,399 | 3,466 | 3,479 | 3,700 | 3,732 | 3,732 | 3,707 |
| Intangible assets | 575 | 412 | 213 | 156 | 153 | 104 | 339 | 294 | 249 | 226 |
| Long-term investments | 929 | 1,143 | 1,568 | 1,703 | 1,538 | 2,055 | 1,980 | 2,281 | 2,787 | 4,327 |
| Other non-current assets | 248 | 265 | 260 | 229 | 691 | 345 | 314 | 806 | ||
| Total assets | 14,570 | 19,419 | 17,633 | 19,024 | 22,353 | 25,825 | 26,726 | 30,729 | 34,409 | 36,299 |
| Accounts payable | 813 | 945 | 996 | 958 | 1,124 | 1,472 | 1,755 | 1,478 | 1,570 | 1,978 |
| Accrued liabilities | 517 | 666 | 639 | 559 | 800 | 924 | 905 | 1,024 | 1,188 | 1,221 |
| Deferred revenue | 905 | 1,284 | 1,201 | 1,336 | 1,321 | 2,076 | 3,142 | 2,975 | 2,849 | 2,566 |
| Short-term debt | 200 | 0 | 0 | 600 | 0 | 0 | 0 | 700 | 0 | |
| Total current liabilities | 3,632 | 4,115 | 3,922 | 4,447 | 4,459 | 6,344 | 7,379 | 7,372 | 8,468 | 7,999 |
| Long-term debt | 3,125 | 5,304 | 5,309 | 4,713 | 5,448 | 5,452 | 5,457 | 5,461 | 5,460 | 6,455 |
| Lease liabilities | 0 | 195 | 228 | 287 | 252 | 259 | 404 | |||
| Other non-current liabilities | 77 | 99 | 126 | 163 | 662 | 692 | 732 | 714 | 810 | 1,074 |
| Total liabilities | 7,353 | 10,070 | 10,788 | 10,810 | 11,775 | 13,578 | 14,532 | 14,380 | 15,408 | 15,884 |
| Total debt | 3,125 | 5,304 | 5,309 | 5,313 | 5,448 | 5,452 | 5,457 | 5,461 | 6,160 | 6,455 |
| Paid-in capital | 6,809 | 7,056 | 7,274 | 7,595 | 7,904 | 8,247 | 8,593 | 9,131 | 9,660 | 10,333 |
| Retained earnings | 15,252 | 18,258 | 20,880 | 24,386 | 27,209 | 32,246 | 37,892 | 43,726 | 49,651 | 55,227 |
| Treasury stock | -14,740 | -15,912 | -21,194 | -23,596 | -24,245 | -27,995 | -34,097 | -36,299 | -40,150 | -45,043 |
| Other comprehensive income | -115 | -64 | -125 | -180 | -299 | -260 | -202 | -217 | -168 | -110 |
| Shareholders' equity | 7,413 | 9,630 | 6,845 | 8,214 | 10,578 | 12,247 | 12,194 | 16,349 | 19,001 | 20,415 |
| Total equity | 7,413 | 9,630 | 6,845 | 8,214 | 10,578 | 12,247 | 12,194 | 16,349 | 19,001 | 20,415 |
| Total liabilities and equity | 14,570 | 19,419 | 17,633 | 19,024 | 22,353 | 25,825 | 26,726 | 30,729 | 34,409 | 36,299 |
| Shares outstanding | 1,078 | 1,060 | 967 | 916 | 914 | 892 | 844 | 833 | 818 | 793 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 1,721 | 3,519 | 3,038 | 2,706 | 3,619 | 5,888 | 6,525 | 6,856 | 7,177 | 6,998 |
| Depreciation and amortization | 389 | 407 | 457 | 363 | 376 | 394 | 444 | 515 | 392 | 435 |
| Stock-based compensation | 201 | 220 | 258 | 263 | 307 | 346 | 413 | 490 | 577 | 668 |
| Deferred income tax | -21 | -12 | 198 | 51 | 68 | 60 | 195 | -358 | -678 | 1,153 |
| Change in receivables | -542 | -37 | 16 | -207 | -427 | -1,989 | -1,109 | 903 | -69 | 49 |
| Change in inventory | -216 | -809 | -1,014 | 248 | -421 | -405 | -1,590 | 207 | 304 | -494 |
| Change in payables | 184 | 371 | 170 | -247 | 327 | 465 | 390 | -138 | 281 | 307 |
| Cash from operations | 2,566 | 3,789 | 3,787 | 3,247 | 3,804 | 5,442 | 5,399 | 8,700 | 8,677 | 7,958 |
| Capital expenditures | -253 | -345 | -622 | -441 | -422 | -668 | -787 | -1,106 | -1,190 | -2,260 |
| Acquisitions | -16 | -68 | -6 | -28 | -107 | -12 | -441 | -25 | 0 | -29 |
| Purchases of investments | -1,390 | -4,856 | -2,077 | -1,914 | -1,355 | -2,007 | -1,492 | -1,672 | -3,588 | -6,054 |
| Sales and maturities of investments | 1,234 | 2,743 | 3,276 | 1,940 | 1,754 | 1,471 | 1,363 | |||
| Cash from investing | -425 | -2,526 | 571 | -443 | -130 | -1,216 | -1,357 | -1,535 | -2,327 | -2,782 |
| Debt issued | 0 | 2,176 | 0 | 0 | 2,979 | 0 | 0 | 0 | 694 | 991 |
| Debt repaid | -1,207 | -205 | 0 | 0 | -2,882 | 0 | 0 | 0 | 0 | -700 |
| Stock issued | 88 | 97 | 124 | 145 | 174 | 175 | 199 | 227 | 243 | 261 |
| Share buybacks | -1,892 | -1,172 | -5,283 | -2,403 | -649 | -3,750 | -6,103 | -2,189 | -3,823 | -4,895 |
| Dividends paid | -444 | -430 | -605 | -771 | -787 | -838 | -873 | -975 | -1,192 | -1,384 |
| Cash from financing | -3,532 | 341 | -5,928 | -3,115 | -1,337 | -4,591 | -7,043 | -3,032 | -4,470 | -5,977 |
| Net change in cash | -1,391 | 1,604 | -1,570 | -311 | 2,337 | -365 | -3,001 | 4,133 | 1,880 | -801 |
| Free cash flow | 2,313 | 3,444 | 3,165 | 2,806 | 3,382 | 4,774 | 4,612 | 7,594 | 7,487 | 5,698 |
| Interest paid | 151 | 186 | 219 | 219 | 219 | 205 | 205 | 205 | 205 | 239 |
| Income taxes paid | 157 | 194 | 300 | 522 | 542 | 851 | 1,869 | 1,006 | 957 | 1,504 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 49.4% | Gross profit / revenue. |
| Operating margin | 29.6% | Operating income / revenue. |
| EBITDA margin | 31.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 34.8% | Pre-tax income / revenue. |
| Net margin | 30.1% | Net income / revenue. |
| FCF margin | 18.2% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 27.2% | Cash from operations / revenue. |
| Effective tax rate | 13.6% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 36.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 21.3% | Net income / average total assets. |
| Return on invested capital (ROIC) | 31.5% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 12.9% | Research and development expense / revenue. |
| SG&A / revenue | 5.4% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 2.3% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 9.0% | Capital expenditures / revenue. |
| D&A / revenue | 1.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 4.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 3.2% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 10.5% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 7.1% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 4.8% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 12.4% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 5.4% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 2.1% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 13.7% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 5.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 2.0% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 13.0% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -2.5% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 2.4% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 14.1% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 0.6% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 5.2% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 17.2% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -8.3% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 13.8% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 15.9% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -23.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 7.3% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 11.0% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 17.1% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Dividend per share CAGR, 3y | 20.4% | Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share CAGR, 5y | 15.4% | Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 7.4% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 18.7% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 14.1% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 5.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 10.7% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 10.2% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -3.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -2.7% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -2.6% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.42x | Current assets / current liabilities. |
| Quick ratio | 1.63x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.89x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.25x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 14.8% | Total debt / total assets. |
| Liabilities / assets | 41.1% | Total liabilities / total assets. |
| Net debt | -$2.79B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | -0.29x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 33.0x | Operating income / interest expense. |
| Working capital | $14.74B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 9.6% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $21.44B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.71x | Revenue / average total assets. |
| Fixed asset turnover | 5.50x | Revenue / average property, plant and equipment. |
| Inventory turnover | 2.38x | Cost of revenue / average inventory. |
| Days inventory | 154 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 4.01x | Revenue / average receivables. |
| Days sales outstanding | 91 days | 365 x average receivables / revenue. |
| Days payables | 56 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 189 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 60.7% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 33.0% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $11.58 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $38.55 | Revenue / diluted weighted shares. |
| FCF per share | $7.03 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $10.50 | Cash from operations / diluted weighted shares. |
| Book value per share | $32.03 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $26.80 | Tangible book value / shares outstanding. |
| Cash per share | $11.54 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 16.3% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 26.9% | Dividends paid / free cash flow, when free cash flow is positive. |
| Buybacks / FCF | 36.1% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $385.07B | Share price x shares outstanding. |
| Enterprise value | $382.28B | Market cap + total debt - cash - short-term investments. |
| P/E | 41.6x | Market cap / net income. Only when net income is positive. |
| P/S | 12.5x | Market cap / revenue. |
| P/B | 15.0x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 18.0x | Market cap / tangible book value, when positive. |
| P/FCF | 68.5x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 45.9x | Market cap / cash from operations, when positive. |
| EV/Sales | 12.4x | Enterprise value / revenue. |
| EV/EBIT | 41.8x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 39.5x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 68.0x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 1.5% | Free cash flow / market cap. |
| Earnings yield | 2.4% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 0.4% | Dividends paid over the period / market cap. |
| Shareholder yield | 0.9% | (Dividends paid + share buybacks) / market cap. |
| PEG | 8.00x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was APPLIED MATERIALS INC /DE's revenue in fiscal 2025?
APPLIED MATERIALS INC /DE reported revenue of $28.37B for fiscal 2025, 4.4% higher than the year before.
Was APPLIED MATERIALS INC /DE profitable in fiscal 2025?
Yes. Net income was $7.00B, a net margin of 24.7%.
How much free cash flow did APPLIED MATERIALS INC /DE generate in fiscal 2025?
Cash from operations of $7.96B minus capital expenditures of $2.26B left free cash flow of $5.70B.